2002
DOI: 10.1055/s-2002-20093
|View full text |Cite
|
Sign up to set email alerts
|

Empfehlungen zur Therapie des Bronchialkarzinoms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
3

Year Published

2003
2003
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(7 citation statements)
references
References 41 publications
0
4
0
3
Order By: Relevance
“…In 7 patients, the diagnosis of SPLC was determined by autopsy and 2 patients died from their cancer during the time of diagnostics. Treatment strategies were planned according to the interdisciplinary guidelines of the Cancer Center Halle [5] following the recommendations on the therapy of bronchial carcinoma of the German Association of Thoracic Surgery [6]. The treatment of the patients depended on the tumor staging, histology and functional status.…”
Section: Methodsmentioning
confidence: 99%
“…In 7 patients, the diagnosis of SPLC was determined by autopsy and 2 patients died from their cancer during the time of diagnostics. Treatment strategies were planned according to the interdisciplinary guidelines of the Cancer Center Halle [5] following the recommendations on the therapy of bronchial carcinoma of the German Association of Thoracic Surgery [6]. The treatment of the patients depended on the tumor staging, histology and functional status.…”
Section: Methodsmentioning
confidence: 99%
“…Under palliative intention doses of 30-40 Gy are considered to be sufficient, doses of ≥ 50 Gy are not applied. For curatively intented radiation therapies, however, doses of at least 60 Gy are required [7,31]. Information on dose was available from all 188 patients.…”
Section: Radiation Therapy Parametersmentioning
confidence: 99%
“…It appears to improve prognosis, and different protocols are currently being investigated in prospective trials. 1 The response to neoadjuvant therapy is commonly assessed by means of anatomic imaging to document the change in size of malignant lesions. This fails to provide information on the biologic behavior of residual masses (eg, tumor viability).…”
mentioning
confidence: 99%